📋 Tender Overview
Contract awarded for Various medications iii lot-0018, title: calcium folinate sol. inj./perf. 10mg/ml vial, description: the estimated value of the largest subsequent contract anticipated to be awarded during the framework agreement: 2,650.00 lei excluding vat. estimates of the minimum and maximum quantities that may be requested during the entire framework agreement: minimum quantities 1 vial, maximum quantities 250 vials. estimated calendar (frequency and value of contracts to be awarded): subsequent contracts will be concluded in a cascading manner depending on needs and the financial provisions allocated for this purpose: monthly/semi-annually/quarterly. in the event that the economic operator signing this framework agreement ranked first is unable to fully respond to the request (inability to ensure the entire requested quantity, non-compliance with the assumed conditions regarding quality, delivery time, price, validity, etc.), the contracting authority will send requests to the occupant of the second place, and in case of denial/lack of response from this one, to the occupant of the third place (when the framework agreement is signed with 3 economic operators), following that the operator/operators ranked first, second, and/or third will bear the consequences for non-fulfillment of the obligations assumed, according to the provisions of art.111 para. (2) and (3) of h.g. 395/2016, with subsequent amendments and completions. lot-0057, title: heparin 5000ui/1ml 5ml vials, description: the estimated value of the largest subsequent contract anticipated to be awarded during the framework agreement: 14,990.00 lei excluding vat. estimates of the minimum and maximum quantities that may be requested during the entire framework agreement: minimum quantities 1 vial, maximum quantities 1200 vials. estimated calendar (frequency and value of contracts to be awarded): subsequent contracts will be concluded in a cascading manner depending on needs and the financial provisions allocated for this purpose: monthly/semi-annually/quarterly. in the event that the economic operator signing this framework agreement ranked first is unable to fully respond to the request (inability to ensure the entire requested quantity, non-compliance with the assumed conditions regarding quality, delivery time, price, validity, etc.), the contracting authority will send requests to the occupant of the second place, and in case of denial/lack of response from this one, to the occupant of the third place (when the framework agreement is signed with 3 economic operators), following that the operator/operators ranked first, second, and/or third will bear the consequences for non-fulfillment of the obligations assumed, according to the provisions of art.111 para. (2) and (3) of h.g. 395/2016, with subsequent amendments and completions. lot-0080, title: nicardipine sol.inj. 10mg/ml, description: the estimated value of the largest subsequent contract anticipated to be awarded during the framework agreement: 5,640.00 lei excluding vat. estimates of the minimum and maximum quantities that may be requested during the entire framework agreement: minimum quantities 1 vial, maximum quantities 380 vials. estimated calendar (frequency and value of contracts to be awarded): subsequent contracts will be concluded in a cascading manner depending on needs and the financial provisions allocated for this purpose: monthly/semi-annually/quarterly. in the event that the economic operator signing this framework agreement ranked first is unable to fully respond to the request (inability to ensure the entire requested quantity, non-compliance with the assumed conditions regarding quality, delivery time, price, validity, etc.), the contracting authority will send requests to the occupant of the second place, and in case of denial/lack of response from this one, to the occupant of the third place (when the framework agreement is signed with 3 economic operators), following that the operator/operators ranked first, second, and/or third will bear the consequences for non-fulfillment of the obligations assumed, according to the provisions of art.111 para. (2) and (3) of h.g. 395/2016, with subsequent amendments and completions. estimated value excluding vat: 13923.20 ron.Various medications iii